Keum-Hyun Kim
Overview
Explore the profile of Keum-Hyun Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang H, Kim J, Lee H, Kim K, Kim T, Lee C, et al.
Korean Circ J
. 2012 Jul;
42(6):390-6.
PMID: 22787469
Background And Objectives: Poor homing efficiency is one of the major limitations of current stem cell therapy. Magnetic bionanoparticles (MPs) obtained from Magnetospirillum sp. AMB-1 have a lipid bilayer membrane...
2.
Lee E, Kang H, Lee H, Kang S, Kim K, Lee S, et al.
Differentiation
. 2011 Nov;
83(1):92-100.
PMID: 22099180
Human embryonic stem (hES) cells have been successfully maintained using human-cell feeder systems or feeder-free systems. However, despite advances in culture techniques, hES cells require supplementation with fibroblast growth factor...
3.
Lee E, Choi E, Kang S, Kim G, Park J, Kang H, et al.
Mol Ther
. 2011 Nov;
20(1):155-67.
PMID: 22068423
In this study, we established and characterized human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) from four different donors. However, the hUCB-MSCs showed remarkable variations in their therapeutic efficacy for...
4.
Lee E, Lee H, Kang H, Kim K, Hur J, Cho H, et al.
Tissue Eng Part A
. 2009 Nov;
16(2):705-15.
PMID: 19895342
Application of human embryonic stem cells (hESCs) to stem-cell therapy is not feasible because of the risk of tumorigenicity and rejection. In contrast, human mesenchymal stem cells (hMSCs) are free...
5.
Chang S, Lee E, Kang H, Zhang S, Kim J, Li L, et al.
Stem Cells
. 2008 Apr;
26(7):1901-12.
PMID: 18403756
Stem cell transplantation in acute myocardial infarction (AMI) has emerged as a promising therapeutic option. We evaluated the impact of AMI on mesenchymal stem cell (MSC) differentiation into cardiomyocyte lineage....